Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Spironolactone can reduce hair growth in women with hirsutism.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.